In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Hot Line Session 5
Session

Event : ESC Congress 2018

Topic : Other

  • Session type : Late-Breaking Science
  • Date : 28 August 2018
  • Time : 14:30 - 15:45

15 presentations in this session

Opening question - High-STEACS.

Event : ESC Congress 2018

  • Session : Hot Line Session 5

Concluding question - High-STEACS.

Event : ESC Congress 2018

  • Session : Hot Line Session 5

Opening question - POET.

Event : ESC Congress 2018

  • Session : Hot Line Session 5

Concluding question - POET.

Event : ESC Congress 2018

  • Session : Hot Line Session 5

Opening question - AIMS.

Event : ESC Congress 2018

  • Session : Hot Line Session 5

Concluding question - AIMS.

Event : ESC Congress 2018

  • Session : Hot Line Session 5

Discussant review - High-STEACS.

Event : ESC Congress 2018

  • Session : Hot Line Session 5
  • Speaker : C Hamm (Bad Nauheim,DE)

POET - Partial oral treatment of left-sided infectious endocarditis

Event : ESC Congress 2018

  • Session : Hot Line Session 5
  • Speaker : H Bundgaard (Copenhagen,DK)

Discussant review - POET.

Event : ESC Congress 2018

  • Session : Hot Line Session 5
  • Speaker : CP Gale (Leeds,GB)

AIMS - Aortic Irbesartan Marfan Study

Event : ESC Congress 2018

  • Session : Hot Line Session 5
  • Speaker : M Mullen (London,GB)

Discussant review - AIMS.

Event : ESC Congress 2018

  • Session : Hot Line Session 5
  • Speaker : A Evangelista Masip (Barcelona,ES)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are